2012, Number 4
<< Back Next >>
Correo Científico Médico 2012; 16 (4)
Is cause of cervical cancer the infection for human papillomavirus?
Leyva QC, Acosta YN, Leyva MN
Language: Spanish
References: 7
Page:
PDF size: 93.78 Kb.
Text Extraction
No abstract.
REFERENCES
1 Reyes González O, López Méndez A, Ángela Batista Campos A. Caracterización histopatológica y evolución del carcinoma epidermoide infiltrante del cuello uterino. Correo Científico Médico. 2011 [citado 14 nov 2012]; 15(1). Disponible en: http://www.cocmed.sld.cu/no151/pdf/no151ori04.pdf
2 Galani E, Christodoulou C. Human papilloma viruses and cancer in the post-vaccine era. Clin Microbiol Infect. 2009;15(11):977-81.
3 Abreu AL, Souza RP, Gimenes F, Consolaro ME. A review of methods for detect human Papillomavirus infection. Virol J. 2012 [citado 10 nov 2012]; 9(1):262. Disponible en: http://www.virologyj.com/content/pdf/1743-422X-9-262.pdf.
4 Boone JD, Erickson BK, Huh WK. New insights into cervical cancer screening. J Gynecol Oncol. 2012;23(4):282-7.
5 Hutubessy R, Levin A, Wang S, Morgan W, Ally M, John T, et al. A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool. BMC Med. 2012 [citado 15 nov 2012];10(1):136. Disponible en: http://www.biomedcentral.com/1741-7015/10/136.
6 Kiatpongsan S, Campos NG, Kim JJ. Potential benefits of second-generation human papillomavirus vaccines. PLoS One. 2012 [citado 12 nov 2012];7(11). Disponible en: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0048426.
7 Tabrizi SN, Brotherton JM, Kaldor JM, Skinner SR, Cummins E, Liu B, et al. Fall in human papillomavirus prevalence following a national vaccination program. J Infect Dis. 2012;206(11):1645-51.
Full text